Finmika 500mg Injection
Marketer
Biofin Lifesciences
Salt Composition
Amikacin (500mg)
Overview Finmika 500mg Injection
Cefamika 500mg Injection combats a broad spectrum of bacterial infections, including those affecting the urinary system, skeletal system, respiratory system (such as pneumonia), central nervous system, and circulatory system. Prophylactically, it's administered to hospitalized individuals to preempt infections. Its mechanism involves inhibiting bacterial proliferation. Administered intravenously (IV infusion) or intramuscularly by a healthcare professional, self-administration is strictly prohibited. Adherence to the prescribed dosage schedule, with evenly spaced intervals, is crucial. Complete the entire course, even with symptom improvement; premature cessation may result in relapse or exacerbation. Common adverse effects encompass injection site inflammation and elevated blood urea nitrogen. Persistent side effects or treatment inefficacy necessitate medical consultation. High dosages might induce disequilibrium, nephrotoxicity, and ototoxicity. Strict adherence to medical guidance is paramount, potentially including regular kidney, hearing, and urine assessments. Pregnancy is a contraindication; disclose pregnancy, pregnancy plans, or breastfeeding to your physician.
Uses of Finmika 500mg Injection
Infections caused by bacteria
Major Benefits of Finmika 500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Finmika 500mg Injection:
- Increased blood urea
- Injection site reactions (pain, swelling, redness)
How to use Finmika 500mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Finmika 500mg Injection works:
Finmika 500mg Injection is a bacterial growth inhibitor, functioning as an antibiotic by disrupting the production of proteins crucial for bacterial survival.
SAFETY ADVICE
AlcoholSAFE
There are no known adverse reactions associated with the concurrent use of alcohol and Finmika 500mg Injection.
PregnancyCONSULT YOUR DOCTOR
Administering Finmika 500mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional, life-threatening circumstances, a physician might prescribe it when the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingSAFE IF PRESCRIBED
The injectable formulation of Finmika, 500mg, is considered safe for use while breastfeeding. Research in humans indicates minimal drug transfer to breast milk, posing no apparent risk to the infant.
DrivingUNSAFE
Administering Finmika 500mg Injection could reduce attentiveness, impair visual acuity, and induce drowsiness or dizziness. Driving should be avoided if such effects manifest.
KidneyCAUTION
For individuals with kidney impairment, administration of Finmika 500mg Injection requires careful consideration. A modified dosage of Finmika 500mg Injection might be necessary. Physician consultation is advised.
LiverSAFE IF PRESCRIBED
The use of Finmika 500mg Injection in individuals with liver impairment is likely safe. Existing evidence indicates that dose modification may not be necessary; however, medical advice is recommended.
What if you forget to take Finmika 500mg Injection :
Should you forget a dose of Finmika 500mg Injection, seek advice from your physician.
Facts to Know About Finmika 500mg Injection
| Label | Value |
|---|---|
| Type of Compound | Amino glycoside antibiotics |
| Potential for Dependence | None. |
| Type of Medication | Agents against infection |
| Mechanism of Action | Aminoglycoside antibiotics |
3,018 People bought this recently